Literature DB >> 21394425

Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study.

J Mäkinen1, M Marjamäki, M Haanperä-Heikkinen, H Marttila, L B Endourova, S E Presnova, V Mathys, P Bifani, R Ruohonen, M K Viljanen, H Soini.   

Abstract

Drug resistance and molecular epidemiology of tuberculosis (TB) in the Murmansk region was investigated in a 2-year, population-based surveillance of the civilian population. During 2003 and 2004, isolates from all culture-positive cases were collected (n = 1,226). Prevalence of multi-drug resistance (MDR) was extremely high, as 114 out of 439 new cases (26.0%), and 574 out of 787 previously treated cases (72.9%) were resistant to at least isoniazid (INH) and rifampin (RIF). Spoligotyping of the primary MDR-TB isolates revealed that most isolates grouped to the Beijing SIT1 genotype (n = 91, 79.8%). Isolates of this genotype were further analyzed by IS6110 RFLP. Sequencing of gene targets associated with INH and RIF resistance further showed that the MDR-TB strains are highly homogeneous as 78% of the MDR, SIT1 strains had the same resistance-conferring mutations. The genetic homogeneity of the MDR-TB strains indicates that they are actively transmitted in Murmansk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394425     DOI: 10.1007/s10096-011-1200-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.

Authors:  V Nikolayevsky; T Brown; Y Balabanova; M Ruddy; I Fedorin; F Drobniewski
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates.

Authors:  I G Shemyakin; V N Stepanshina; I Y Ivanov; M Y Lipin; V A Anisimova; A G Onasenko; O V Korobova; T M Shinnick
Journal:  Int J Tuberc Lung Dis       Date:  2004-10       Impact factor: 2.373

4.  New PCR-based assay for detection of common mutations associated with rifampin and isoniazid resistance in Mycobacterium tuberculosis.

Authors:  Svetlana Dubiley; Angelina Mayorova; Anna Ignatova; Eugene Kirillov; Valentina Stepanshina; Alexander Kolesnikov; Igor Shemyakin
Journal:  Clin Chem       Date:  2005-02       Impact factor: 8.327

5.  Molecular epidemiology of drug-resistant tuberculosis in Hungary.

Authors:  Csaba Ködmön; Stefan Niemann; Judit Lukács; Eva Sör; Sándor Dávid; Akos Somoskövi
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

6.  A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.

Authors:  H J Marttila; H Soini; E Eerola; E Vyshnevskaya; B I Vyshnevskiy; T F Otten; A V Vasilyef; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay.

Authors:  H J Marttila; H Soini; B I Vyshnevskiy; T F Otten; A V Vasilyef; P Huovinen; M K Viljanen
Journal:  Scand J Infect Dis       Date:  1998

Review 8.  Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements.

Authors:  D Van Soolingen
Journal:  J Intern Med       Date:  2001-01       Impact factor: 8.989

9.  Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia.

Authors:  A A Baranov; A O Mariandyshev; T Mannsåker; U R Dahle; G A Bjune
Journal:  Int J Tuberc Lung Dis       Date:  2009-10       Impact factor: 2.373

10.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.

Authors:  Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2006-03-06       Impact factor: 3.605

View more
  8 in total

1.  Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.

Authors:  T Tsukatani; H Suenaga; M Shiga; T Ikegami; M Ishiyama; T Ezoe; K Matsumoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-15       Impact factor: 3.267

2.  Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Authors:  Li-Li Zhao; Yan Chen; Hai-Can Liu; Qiang Xia; Xiao-Cui Wu; Qing Sun; Xiu-Qin Zhao; Gui-Lian Li; Zhi-Guang Liu; Kang-Lin Wan
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

Review 3.  Insights into the origin, emergence, and current spread of a successful Russian clone of Mycobacterium tuberculosis.

Authors:  Igor Mokrousov
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

4.  Molecular epidemiology of tuberculosis in Finland, 2008-2011.

Authors:  Pieter Willem Smit; Marjo Haanperä; Pirre Rantala; David Couvin; Outi Lyytikäinen; Nalin Rastogi; Petri Ruutu; Hanna Soini
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

5.  Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review.

Authors:  Aizhamal Tabyshova; Berik Emilov; Maarten J Postma; Niels H Chavannes; Talant Sooronbaev; Job F M van Boven
Journal:  Int J Environ Res Public Health       Date:  2020-10-14       Impact factor: 3.390

6.  Mycobacterium tuberculosis population in northwestern Russia: an update from Russian-EU/Latvian border region.

Authors:  Igor Mokrousov; Anna Vyazovaya; Tatiana Otten; Viacheslav Zhuravlev; Elena Pavlova; Larisa Tarashkevich; Valery Krishevich; Boris Vishnevsky; Olga Narvskaya
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

7.  Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation.

Authors:  Igor Mokrousov; Anna Vyazovaya; Natalia Solovieva; Tatiana Sunchalina; Yuri Markelov; Ekaterina Chernyaeva; Natalia Melnikova; Marine Dogonadze; Daria Starkova; Neliya Vasilieva; Alena Gerasimova; Yulia Kononenko; Viacheslav Zhuravlev; Olga Narvskaya
Journal:  BMC Microbiol       Date:  2015-12-18       Impact factor: 3.605

8.  Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.

Authors:  Daniela Munro-Rojas; Esdras Fernandez-Morales; José Zarrabal-Meza; Ma Teresa Martínez-Cazares; Aurora Parissi-Crivelli; Javier Fuentes-Domínguez; Marie Nancy Séraphin; Michael Lauzardo; Jorge Alberto González-Y-Merchand; Sandra Rivera-Gutierrez; Roberto Zenteno-Cuevas
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.